Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.
Nanostics has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Nanostics's investors include University of Alberta, VA Angels, Canadian Biotechnology Innovation and Commercialization Initiative.
Nanostics is headquartered in Edmonton, Canada.
Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.
Nanostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanostics — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/nanostics. Accessed November 12, 2026.
VCBacked. (2025). Nanostics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/nanostics
{{cite web |title=Nanostics — Funding & Investors |url=https://www.vcbacked.co/company/nanostics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Nanostics? Request a listing update